Duke University
The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.
Inclusion Criteria: * Black and White adults greater than or equal to 18 years of age * Clinical diagnosis of NVAF * CHA2DS2-VASc score greater than or equal to 2 * New patient visit for initiation of oral anticoagulation at primary care and cardiology clinics Exclusion Criteria: * Unable to speak English * Unable to provide informed consent
Patient decision support tool is a web based educational material that informs a patient on the risk and benefits of oral anticoagulation. In addition, such a tool aims to assess patient values and preferences in the decision making process for oral anticoagulation for stroke reduction.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.